194 related articles for article (PubMed ID: 24233155)
1. Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.
Leon IE; Porro V; Di Virgilio AL; Naso LG; Williams PA; Bollati-Fogolín M; Etcheverry SB
J Biol Inorg Chem; 2014 Jan; 19(1):59-74. PubMed ID: 24233155
[TBL] [Abstract][Full Text] [Related]
2. Oxidovanadium(IV) complexes with chrysin and silibinin: anticancer activity and mechanisms of action in a human colon adenocarcinoma model.
León IE; Cadavid-Vargas JF; Tiscornia I; Porro V; Castelli S; Katkar P; Desideri A; Bollati-Fogolin M; Etcheverry SB
J Biol Inorg Chem; 2015 Oct; 20(7):1175-91. PubMed ID: 26404080
[TBL] [Abstract][Full Text] [Related]
3. Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.
Naso LG; Ferrer EG; Butenko N; Cavaco I; Lezama L; Rojo T; Etcheverry SB; Williams PA
J Biol Inorg Chem; 2011 Apr; 16(4):653-68. PubMed ID: 21399988
[TBL] [Abstract][Full Text] [Related]
4. Antitumor properties of a vanadyl(IV) complex with the flavonoid chrysin [VO(chrysin)2EtOH]2 in a human osteosarcoma model: the role of oxidative stress and apoptosis.
Leon IE; Di Virgilio AL; Porro V; Muglia CI; Naso LG; Williams PA; Bollati-Fogolin M; Etcheverry SB
Dalton Trans; 2013 Sep; 42(33):11868-80. PubMed ID: 23760674
[TBL] [Abstract][Full Text] [Related]
5. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.
León IE; Cadavid-Vargas JF; Resasco A; Maschi F; Ayala MA; Carbone C; Etcheverry SB
J Biol Inorg Chem; 2016 Dec; 21(8):1009-1020. PubMed ID: 27696106
[TBL] [Abstract][Full Text] [Related]
7. Antimetastatic effects of VOflavonoid complexes on A549 cell line.
Naso LG; Martínez VR; Ferrer EG; Williams PAM
J Trace Elem Med Biol; 2021 Mar; 64():126690. PubMed ID: 33260045
[TBL] [Abstract][Full Text] [Related]
8. Oxidovanadium(IV) Complex Disrupts Mitochondrial Membrane Potential and Induces Apoptosis in Pancreatic Cancer Cells.
Kowalski S; Tesmar A; Sikorski A; Inkielewicz-Stępniak I
Anticancer Agents Med Chem; 2021; 21(1):71-83. PubMed ID: 32579508
[TBL] [Abstract][Full Text] [Related]
9. Vanadium and cancer treatment: antitumoral mechanisms of three oxidovanadium(IV) complexes on a human osteosarcoma cell line.
León IE; Butenko N; Di Virgilio AL; Muglia CI; Baran EJ; Cavaco I; Etcheverry SB
J Inorg Biochem; 2014 May; 134():106-17. PubMed ID: 24199985
[TBL] [Abstract][Full Text] [Related]
10. Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition.
Wang YX; Cai H; Jiang G; Zhou TB; Wu H
Asian Pac J Cancer Prev; 2014; 15(16):6791-8. PubMed ID: 25169527
[TBL] [Abstract][Full Text] [Related]
11. Antioxidant and anticancer effects and bioavailability studies of the flavonoid baicalin and its oxidovanadium(IV) complex.
Martínez Medina JJ; Naso LG; Pérez AL; Rizzi A; Ferrer EG; Williams PAM
J Inorg Biochem; 2017 Jan; 166():150-161. PubMed ID: 27863301
[TBL] [Abstract][Full Text] [Related]
12. Antioxidant, anticancer activities and mechanistic studies of the flavone glycoside diosmin and its oxidovanadium(IV) complex. Interactions with bovine serum albumin.
Naso L; Martínez VR; Lezama L; Salado C; Valcarcel M; Ferrer EG; Williams PAM
Bioorg Med Chem; 2016 Sep; 24(18):4108-4119. PubMed ID: 27374881
[TBL] [Abstract][Full Text] [Related]
13. Hydroxylamido-amino acid complexes of oxovanadium(V). Toxicological study in cell culture and in a zebrafish model.
León IE; Di Virgilio AL; Barrio DA; Arrambide G; Gambino D; Etcheverry SB
Metallomics; 2012 Dec; 4(12):1287-96. PubMed ID: 23073485
[TBL] [Abstract][Full Text] [Related]
14. New Oxidovanadium(IV) Coordination Complex Containing 2-Methylnitrilotriacetate Ligands Induces Cell Cycle Arrest and Autophagy in Human Pancreatic Ductal Adenocarcinoma Cell Lines.
Kowalski S; Wyrzykowski D; Hac S; Rychlowski M; Radomski MW; Inkielewicz-Stepniak I
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634697
[TBL] [Abstract][Full Text] [Related]
15. Silibinin causes apoptosis and cell cycle arrest in some human pancreatic cancer cells.
Ge Y; Zhang Y; Chen Y; Li Q; Chen J; Dong Y; Shi W
Int J Mol Sci; 2011; 12(8):4861-71. PubMed ID: 21954330
[TBL] [Abstract][Full Text] [Related]
16. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.
Vue B; Zhang S; Zhang X; Parisis K; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Feb; 109():36-46. PubMed ID: 26748997
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the effect of an oxovanadium(iv) complex with the flavonoid chrysin (VOChrys) on intracellular cell signalling pathways in an osteosarcoma cell line.
León IE; Díez P; Etcheverry SB; Fuentes M
Metallomics; 2016 Aug; 8(8):739-49. PubMed ID: 27175625
[TBL] [Abstract][Full Text] [Related]
18. Effect of radiation on cytotoxicity, apoptosis and cell cycle arrest of human osteosarcoma MG-63 induced by a ruthenium(II) complex.
Liu SH; Zhao JH; Deng KK; Wu Y; Zhu JW; Liu QH; Xu HH; Wu HF; Li XY; Wang JW; Guo QF
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Apr; 140():202-9. PubMed ID: 25594209
[TBL] [Abstract][Full Text] [Related]
19. Copper complex with sulfamethazine and 2,2'-bipyridine supported on mesoporous silica microspheres improves its antitumor action toward human osteosarcoma cells: cyto- and genotoxic effects.
Cadavid-Vargas JF; Arnal PM; Mojica Sepúlveda RD; Rizzo A; Soria DB; Di Virgilio AL
Biometals; 2019 Feb; 32(1):21-32. PubMed ID: 30334122
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
